收藏切换
Mining and analysis of adverse events of bevacizumab in ovarian cancer patients based on FAERS database
收藏切换
Meng GAO1, 2, 3, Yu-pei WU2, 3, Miao-miao WANG1, 2, 3, Hui-zhen WU1, 2, 3, *
Chinese Journal of New Drugs | 2026, 35(11) : 1213 - 1221
Less
收藏切换
Chinese Journal of New Drugs | 2026, 35(11): 1213-1221
Mining and analysis of adverse events of bevacizumab in ovarian cancer patients based on FAERS database
Full
Meng GAO1, 2, 3, Yu-pei WU2, 3, Miao-miao WANG1, 2, 3, Hui-zhen WU1, 2, 3, *
Affiliations
  • 1School of Graduate, Hebei Medical University, Shijiazhuang 050017, China
  • 2Department of Pharmacy, Hebei Provincial People's Hospital, Shijiazhuang 050051, China
  • 3Hebei Key Lab of Clinical Pharmacy, Shijiazhuang 050051, China
Published: 2026-06-15 doi: 10.20251/j.cnki.1003-3734.2026.11.012
Outline
收藏切换
Objective:

To mine the adverse events (AEs) related to bevacizumab in ovarian cancer patients from the FDA Adverse Event Reporting System (FAERS) and to reveal their clinical priority information, so as to provide a reference for clinical medication.

Methods:

AE reports related to bevacizumab for ovarian cancer were collected from the FAERS database from the first quarter of 2004 (Q1) to the first quarter of 2025 (Q1). Signal mining was performed using the reporting odds ratio (ROR), proportional reporting ratio (PRR) and Bayesian Confidence Propagation Neural Network (BCPNN) methods, and clinical priority assessment of positive signals was conducted.

Results:

A total of 5 025 reports were include. Physicians were the primary reporters (60.23%), and the United States accounted for the largest proportion of reporters (36.16%). A total of 195 preferred term (PT) signals were identified, spanning 20 System Organ Classes (SOCs). General disorders and administration site conditions was the most frequently reported SOC. Common AEs included hypertension, proteinuria and neutropenia, etc. The median onset time of all AEs was 81 days. Clinical priority classification: 2 PTs were classified as strong priority, 62 PTs as moderate priority, and 131 PTs as weak priority. The strong priority PTs were intestinal perforation and gastrointestinal perforation.

Conclusion:

Based on an extensive analysis of the post-marketing international safety database, this study identified common AEs associated with bevacizumab in ovarian cancer patients, and highlighted the need for close monitoring of intestinal perforation and gastrointestinal perforation, providing a reference for clinical medication and pharmacovigilance.

bevacizumab  /  ovarian cancer  /  adverse event  /  FDA Adverse Event Reporting System  /  signal mining
高萌, 吴玉佩, 王苗苗, 吴惠珍. 基于FAERS数据库的卵巢癌患者应用贝伐珠单抗不良事件挖掘与分析. 中国新药杂志, 2026 , 35 (11) : 1213 -1221 . DOI: 10.20251/j.cnki.1003-3734.2026.11.012
Meng GAO, Yu-pei WU, Miao-miao WANG, Hui-zhen WU. Mining and analysis of adverse events of bevacizumab in ovarian cancer patients based on FAERS database[J]. Chinese Journal of New Drugs, 2026 , 35 (11) : 1213 -1221 . DOI: 10.20251/j.cnki.1003-3734.2026.11.012
Year 2026 volume 35 Issue 11
54
7
Cite this Article
BibTeX
Article Info
doi: 10.20251/j.cnki.1003-3734.2026.11.012
  • Online Date:2026-10-26
  • Published:2026-06-15
Article Data
Affiliations
History
  • Accepted:2025-12-20
Funding
Affiliations
    1School of Graduate, Hebei Medical University, Shijiazhuang 050017, China
    2Department of Pharmacy, Hebei Provincial People's Hospital, Shijiazhuang 050051, China
    3Hebei Key Lab of Clinical Pharmacy, Shijiazhuang 050051, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/10.20251/j.cnki.1003-3734.2026.11.012
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT